drugset / Trial / NCT01959204

Evaluate The Pharmacokinetics and Safety Of Oxycodone Oral Solution In Pediatric and Adolescent Subjects

NCT01959204

Phase 4 Completed 97 enrolled VistaPharm, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to characterize the pharmacokinetics and to evaluate the safety of single and multiple doses of Oxycodone Oral Solution in pediatric and adolescent subjects for postoperative pain.

Timeline

Start
2013-10-14
Primary completion
2019-08-21
Completion
2019-08-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 0.07 mg/kg Oral
Subject Oxycodone Other / unclassified 0.08 mg/kg Oral
Subject Oxycodone Other / unclassified 0.1 mg/kg Oral

Indications

No indication recorded.